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Introduction Congenital intracranial tumors are rare and often incidentally diagnosed
on routine ultrasound. We report a case of a fetal demise with a massive intracranial
teratoma at 25 weeks of gestation and the management of her delivery in the setting of
macrocephaly, breech presentation, and polyhydramnios.
Case A 31-year-old G3P1011 woman at 25 weeks’ gestation presented with a recent
fetal demise and a fetal intracranial tumor ﬁrst identiﬁed at 16 weeks’ gestational
age. The patient had declined termination of pregnancy. Biometry was consistent
with 24 weeks’ gestation, except for a head circumference of 394.4 mm consistent
with 39 weeks’ gestation. The fetus was in a breech presentation. An external
cephalic version (ECV) was successfully performed under epidural anesthesia and an
amnioreduction was then performed to stabilize the fetal position. Immediate
induction of labor and vaginal delivery followed.
Discussion ECV and amnioreduction may help facilitate delivery in cases of fetal
demise complicated by macrocephaly, malpresentation, and polyhydramnios.

Fetal brain tumors are exceedingly rare, accounting for 0.5
to 1.5% of all childhood brain tumors, with an estimated
incidence of 1.1 to 3.4 per million live births.1 Although
partially dependent on location and histologic type, they
are usually associated with a poor fetal prognosis. Early
cesarean delivery or termination before viability, employing destructive operations when appropriate, may help
avoid obstetric complications because of the cephalopelvic
disproportion. Here, we present a case of a massive immature fetal intracranial teratoma with antenatal cranial
perforation and the management of her delivery in the
setting of macrocephaly, breech presentation, and
polyhydramnios.
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Case Report
A 31-year-old woman, G3P1011 at 16 weeks’ gestational age
was found to have a fetus with an intracranial mass on
ultrasound. The lesion progressively grew with signiﬁcant
distortion of intracranial skull anatomy at 20 weeks. She was
counseled at both visits regarding the dismal prognosis and
was offered termination. At 252/7 weeks’ gestational age, she
presented for a maternal–fetal medicine consultation regarding the large fetal intracranial mass. Her history was remarkable for a previous ﬁrst trimester elective termination
followed by a term vaginal delivery. At the time of consultation, a fetal demise with hydrops was discovered on
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ultrasound. Fetal biometry was consistent with 24 weeks’
gestational age based on long bone measurements, but the
fetal head circumference was 394.4 mm consistent with
39 weeks’ gestational age. An 8  10 cm heterogeneous
intracranial mass (►Fig. 1) was identiﬁed and the fetus was
in breech presentation.
Given the high concern for fetal head entrapment during a
breech delivery, an external cephalic version (ECV) was
attempted but was unsuccessful, likely because of the poor
fetal tone and the relatively small fetal torso. Management
options that were subsequently considered included another
ECV attempt under regional anesthesia, hysterotomy, or
dilation and evacuation with cranial destruction. The patient
was highly motivated to have a vaginal delivery and wanted to
avoid surgery. She was admitted to Labor and Delivery for ECV
under epidural anesthesia. Because of the early gestational
age, polyhydramnios, and extreme macrocephaly, there was
concern that the fetus would return to a breech presentation,
even in the setting of a fetal demise. Therefore, an amnioreduction was recommended to assist in maintaining the fetus
in a cephalic presentation during induction of labor. A sterile
amniocentesis procedure was performed under continuous
ultrasound guidance with a 20-gauge needle and approximately 1,200 mL of murky brown ﬂuid was obtained via
suction. Following the version, ultrasound demonstrated a
posterior defect in the cranium. It remains unclear whether
this defect was present before or as a consequence of the
version. Alpha-fetoprotein levels in the amniotic ﬂuid were
elevated.
The patient was induced with 200 µg misoprostol administered vaginally for two doses 3 hours apart and then started
on oxytocin. During delivery, the intracranial mass was
propelled through the posterior cranial defect. She ultimately
had a vaginal delivery and was discharged home the following
morning. The ﬁnal pathology report described a female fetus
(►Fig. 2) with a congenital intracranial immature teratoma
completely replacing the brain and hydrops fetalis. The tumor
weighed 186 g.
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Fig. 1 Ultrasound demonstrating massive intracranial mass at
25 weeks’ gestation.

Discussion
Congenital intracranial tumors are very rare and often incidentally diagnosed on routine second or third trimester
ultrasound. They are frequently associated with macrocephaly, hydrocephalus, bulging anterior fontanel, or polyhydramnios.2 Teratomas, as presented in this case, are the most
common histologic subtype, accounting for between 36 to
62% of congenital brain tumors; they are most often located
supratentorially and are composed of tissue derived from all
the following three embryonic germ layers: endoderm, mesoderm, and ectoderm.3,4 Further classiﬁcation, as mature or
immature, is based on the degree of tissue differentiation.
Rapid, invasive tumor growth that destroys and obliterates
normal cerebral and cranial structures is responsible for the
poor fetal prognosis. The 1-year survival rate is less than 10%.
Survivors typically have profound developmental delay.3
Intrauterine treatment remains an investigational procedure.
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Fig. 2 Macroscopic appearance of the newborn.
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ECV following an intrauterine fetal demise is typically
unnecessary. With a live fetus undergoing a vaginal breech
delivery, there is an increased risk of head entrapment and
other fetal injuries.5 In addition, few providers are sufﬁciently
skilled to perform these deliveries. In this clinical scenario,
patients are offered an ECV and, if successful, will proceed
with spontaneous or induced labor. With a fetal demise in
breech presentation, surgical delivery should be avoided if
possible given its inherent risks. This case is unusual given the
signiﬁcant fetal head size and the possibility that a breech
delivery could also require a destructive procedure such as
cephalocentesis or craniotomy to deliver the head.6
Decompression amniocentesis has been used in singleton
pregnancies complicated by severe and symptomatic polyhydramnios but no randomized trials have evaluated whether it is superior to expectant management.7 Amnioreduction
following ECV is rarely performed. In this case, because of the
polyhydramnios and extreme macrocephaly, we felt that this
would optimize the stability of the fetal position until delivery
was achieved. To our knowledge, this type of management
has not been previously reported.
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